BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 9148227)

  • 1. [Azithromycin combined with pyrimethamine in the treatment of neurotoxoplasmosis, in an AIDS patient].
    Trotta M; Sterrantino G; Milo D; Dionisio D; Leoncini F
    Minerva Med; 1997 Mar; 88(3):117-9. PubMed ID: 9148227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toxoplasmic encephalitis in acquired immunodeficiency syndrome.
    Chaddha DS; Kalra SP; Singh AP; Gupta RM; Sanchetee PC
    J Assoc Physicians India; 1999 Jul; 47(7):680-4. PubMed ID: 10778586
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cerebral toxoplasmosis and AIDS in Martinique].
    Bourée P; Dumazedier D; Magdeleine C; Sobesky G
    Med Trop (Mars); 1997; 57(3):259-61. PubMed ID: 9513153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebral toxoplasmosis in childhood and adult HIV infection treated with 1-4 hydroxynaphthoquinone and rapid desensitization with pyrimethamine.
    Bouboulis DA; Rubinstein A; Shliozberg J; Madden J; Frieri M
    Ann Allergy Asthma Immunol; 1995 Jun; 74(6):491-4. PubMed ID: 7788516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pyrimethamine plus azithromycin for treatment of acute toxoplasmic encephalitis in patients with AIDS.
    Saba J; Morlat P; Raffi F; Hazebroucq V; Joly V; Leport C; Vildé JL
    Eur J Clin Microbiol Infect Dis; 1993 Nov; 12(11):853-6. PubMed ID: 8112357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Twice-weekly pyrimethamine-sulfadoxine effectively prevents Pneumocystis carinii pneumonia relapse and toxoplasmic encephalitis in patients with AIDS.
    Schürmann D; Bergmann F; Albrecht H; Padberg J; Grünewald T; Behnsch M; Grobusch M; Vallée M; Wünsche T; Ruf B; Suttorp N
    J Infect; 2001 Jan; 42(1):8-15. PubMed ID: 11243747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-escalation, phase I/II study of azithromycin and pyrimethamine for the treatment of toxoplasmic encephalitis in AIDS.
    Jacobson JM; Hafner R; Remington J; Farthing C; Holden-Wiltse J; Bosler EM; Harris C; Jayaweera DT; Roque C; Luft BJ;
    AIDS; 2001 Mar; 15(5):583-9. PubMed ID: 11316995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Value of magnetic resonance in the diagnostic definition of neurotoxoplasmosis and in the assessment of the response to pharmacological treatment].
    Sparacia G; Brancatelli G; Sarno C; De Maria M; Lagalla R; Filosto L
    Radiol Med; 1998; 96(1-2):23-8. PubMed ID: 9819614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Choreoathetosis in acquired immune deficiency syndrome patients with cerebral toxoplasmosis.
    Maggi P; de Mari M; De Blasi R; Armenise S; Romanelli C; Andreula C; Zimatore G; Angarano G
    Mov Disord; 1996 Jul; 11(4):434-6. PubMed ID: 8813225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Randomized controlled trial of pyrimethamine plus sulfadiazine versus trimethoprim plus sulfamethoxazole for treatment of toxoplasmic encephalitis in AIDS patients.
    Kongsaengdao S; Samintarapanya K; Oranratnachai K; Prapakarn W; Apichartpiyakul C
    J Int Assoc Physicians AIDS Care (Chic); 2008; 7(1):11-6. PubMed ID: 17517949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alternative treatment approach to cerebral toxoplasmosis in HIV/AIDS: experience from a resource-poor setting.
    Goswami RP; Goswami RP; Rahman M; Ray Y; Tripathi SK
    Int J STD AIDS; 2015 Oct; 26(12):864-9. PubMed ID: 25411350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic alternatives for cases of cerebral toxoplasmosis in patients with AIDS: clarithromycin and atovaquone].
    Guelar A; Miró JM; Mallolas J; Zamora L; Cardenal C; Gatell JM; Soriano E
    Enferm Infecc Microbiol Clin; 1994 Mar; 12(3):137-40. PubMed ID: 8011719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Response to oral and intravenous azithromycin in a patient with toxoplasma encephalitis and AIDS.
    Wiselka MJ; Read R; Finch RG
    J Infect; 1996 Nov; 33(3):227-9. PubMed ID: 8945715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cerebral toxoplasmosis].
    Ribera Pascuet E; López Aldeguer J; Pérez Elías MJ; Podzamczer Palter D
    Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():45-51. PubMed ID: 9859619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central nervous system toxoplasmosis in adult Ethiopians.
    Amogne W; Teshager G; Zenebe G
    Ethiop Med J; 2006 Apr; 44(2):113-20. PubMed ID: 17447372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New pathogens and mode of action of azithromycin: Toxoplasma gondii].
    Derouin F
    Pathol Biol (Paris); 1995 Jun; 43(6):561-4. PubMed ID: 8539083
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrimethamine-clindamycin vs. pyrimethamine-sulfadiazine as acute and long-term therapy for toxoplasmic encephalitis in patients with AIDS.
    Katlama C; De Wit S; O'Doherty E; Van Glabeke M; Clumeck N
    Clin Infect Dis; 1996 Feb; 22(2):268-75. PubMed ID: 8838183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clarithromycin combined with pyrimethamine in cerebral toxoplasmosis--a report of 2 cases].
    Dalston MO; Tavares W; Bazin AR; Hahn MD; dos Santos AA; Pimentel T; Mello JN
    Rev Soc Bras Med Trop; 1995; 28(4):409-13. PubMed ID: 8668843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toxoplasmic encephalitis in patients with the acquired immunodeficiency syndrome. Members of the ACTG 077p/ANRS 009 Study Team.
    Luft BJ; Hafner R; Korzun AH; Leport C; Antoniskis D; Bosler EM; Bourland DD; Uttamchandani R; Fuhrer J; Jacobson J
    N Engl J Med; 1993 Sep; 329(14):995-1000. PubMed ID: 8366923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Azithromycin: new orientations].
    Coulaud JP
    Pathol Biol (Paris); 1995 Jun; 43(6):547-50. PubMed ID: 8539080
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.